Efficacy and cost of high-frequency IGRT in elderly stage III non-small-cell lung cancer patients. Heilbroner SP, Xanthopoulos EP, Buono D, Carrier D, et al. PLoS One 2021;16:e0252053.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Heilbroner SP, Xanthopoulos EP, Buono D, Carrier D, et al. Efficacy and cost of high-frequency IGRT in elderly stage III non-small-cell lung cancer patients. PLoS One 2021;16:e0252053.
PMID: 34043677